Trial Profile
A Phase 2, open-label study of Burixafor in allogeneic poor mobilizers
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Mar 2015
Price :
$35
*
At a glance
- Drugs Burixafor (Primary)
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 26 Mar 2015 New trial record